Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients

Journal of Endocrinology

Volumn 181, Issue 3, 2004, Pages 419-427

  Torres, S H ^a   De Sanctis, J B ^a   de L Briceno M ^b   Hernandez N ^a   Finol, H J ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CD40 LIGAND; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; METFORMIN; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MACROPHAGE; MALE; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; MUSCLE BIOPSY; MUSCLE INJURY; MYOSITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RANK SUM TEST; SKELETAL MUSCLE; ULTRASTRUCTURE;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, CELL SURFACE; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042842603     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1810419     Document Type: Article

References (34)

1. Adams W, Nehrhoff B, Späte U, Linke A, Schulze PC, Baur A, Gielen S, Hambrecht R & Schuler G 2002 Induction of iNOS expression in skeletal muscle by IL-1β and NFκB activation: an in vitro and in vivo study. Cardiovascular Research 54 95-104.
2. Beck K-F, Eberhardt W, Frank S, Huwiler A, Messmer UK, Mühl H & Pfeilschifter J 1999 inducible NO synthase: role in cellular signaling. Journal of Experimental Biology 202 645-653.
3. Beckman JS & Koppenol WH 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. American Journal of Physiology 271 C1424-C1427.
4. Bedard S, Marcotte B & Marette A 1998 Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells. Diabetologia 41 1523-1527.
5. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L & Taboga C 2001 Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44 834-838.
6. Cosentino F, Hishikawa K, Katusic Z & Lüscher TF 1997 High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96 25-28.
7. Di Mario U & Pugliese G 2001 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 44 674-692.
8. Graversen JH, Madsen M & Moestrup SK 2002 CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. International Journal of Biochemistry and Cell Biology 34 309-314.
9. Green LC, Wagner DA, Glogowski J, Skipper DL, Whisnok JS & Tannenbaum SR 1982 Analysis of nitrate, nitrite and 15n-nitrate in biological fluids. Analytical Biochemistry 126 131-138.
10. Malm C, Nyberg P, Engström M, Sjódin B, Lenkei R, Ekblom B & Lundberg I 2000 Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. Journal of Physiology 529 243-262.
11. Marette A 2002 Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Current Opinion in Clinical Nutrition and Metabolic Care 5 377-383.
12. Marx N, Imhof A, Froehlich J, Siam L, Ittner J, Wierse G, Schmidt A, Maerz W, Hombach V & Koening W 2003 Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation 107 1954-1957.
13. Moncada S, Palmer RMJ & Higgs EA 1991 Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43 109-142.
14. Moshage H, Kok B, Huizenga JR & Jansen PL. 1995 Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry 4 892-896.
15. Nishigaki R, Guo F, Onda M, Yamada N, Yokoyama M, Naito Z, Asano G, ShimizuSuganuma M, Shichinohe K & Aramaki T 1999 Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NFκB in aorta of streptozotocin treated Mongolian gerbils. Nippon Ika Daigaku Zasshi 66 166-175.
16. Nishikawa T, Edelstein D, Du XL, Yamagushi S-I, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates P, Hammes H-P et al. 2000 Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 787-790.
17. Perreault M & Marette A 2001 Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nature Medicine 7 1138-1143.
18. Pickup JC, Chusney GD, Thomas SM & Burt D 2000 Plasma interlukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sciences 67 291-300.
19. Pieper GM 1998 Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension 31 1047-1060.
20. Schmidt HHHW, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD & Feelisch M. 1996 No. NO from NO synthase. PNAS 93 14492-14497.
21. Stamler JS & Meissner G 2001 Physiology of nitric oxide in skeletal muscle. Physiological Reviews 81 209-237.
22. Sulahian TH, Hintz KA, Wardnell K & Guyre PM 2001 Development of an ELISA to measure soluble CD163 in biological fluids. Journal of Immunological Methods 252 25-31.
23. Vallejo S, Angulo J, Peiró C, Nevado J, Sánchez-Ferrer A, Petidier R, Sánchez-Ferrer CF & Rodríguez-Mañ as L 2000 High glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia 43 83-90.
24. van der Veen RC 2001 Nitric oxide and T helper cell immunity. International Immunopharmacology 1 1491-1500.
25. van Kooten C & Banchereau J 2000 CD40-CD40 ligand. Journal of Leukocyte Biology 67 2-17.
26. Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual AL, Bernal MR, Fernández-Cruz A, Veves A, Jarolim P, Varo JJ et al. 2003 Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. A novel target of thiazolidinediones. Circulation 107 2664-2669.
27. Wang MX, Murrel DF, Szabo C, Warren RF, Sarris M & Murrell GA 2001 Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric Oxide 5 219-232.
28. Wang W, Wang S, Yan L, Madara P, Cintron ADP, Wesley RA & Danner RL 2000 Superoxide production and reactive oxygen species. Signaling by endothelial nitric-oxide synthase. Journal of Biological Chemistry 275 16899-16903.
29. Wautier M-P, Chappey O, Corda S, Stern DM, Schmidt AM & Wautier J-L 2001 Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology 280 E685-E694.
30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW Jr 2003 Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112 1796-1808.
31. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA et al. 2003 Chonic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112 1821-1830.
32. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D & Stern D 1994 Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptor/binding proteins. Journal of Biological Chemistry 269 9889-9897.
33. Ye YZ, Strog M, Huang Z-Q & Beckman JS 1996 Antibodies that recognize nitrotyrosine. Methods in Enzymology 269 201-209.
34. Zou M-H, Shi C & Cohen RA 2002 High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51 198-203.